Adoptive Cellular Therapy (ACT) for Cancer Treatment
Author:
Publisher
Springer Netherlands
Link
http://link.springer.com/content/pdf/10.1007/978-94-017-7555-7_4
Reference375 articles.
1. Ahmadi, M., King, J. W., et al. (2011). CD3 limits the efficacy of TCR gene therapy in vivo. Blood, 118(13), 3528–3537.
2. Ahmadzadeh, M., Johnson, L. A., et al. (2009). Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood, 114(8), 1537–1544.
3. Airoldi, I., Bertaina, A., et al. (2015). gammadelta T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-alphabeta+/CD19+ lymphocytes. Blood, 125(15), 2349–2358.
4. Alexander, S., & Friedl, P. (2012). Cancer invasion and resistance: Interconnected processes of disease progression and therapy failure. Trends in Molecular Medicine, 18(1), 13–26.
5. Altvater, B., Landmeier, S., et al. (2009). 2B4 (CD244) signaling by recombinant antigen-specific chimeric receptors costimulates natural killer cell activation to leukemia and neuroblastoma cells. Clinical Cancer Research, 15(15), 4857–4866.
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Enhancing the safety of CAR-T cell therapy: Synthetic genetic switch for spatiotemporal control;Science Advances;2024-02-23
2. Role of regulatory T cells in pathogenesis and therapeutics of rheumatoid arthritis and juvenile idiopathic arthritis;Regulatory T Cells and Autoimmune Diseases;2024
3. Preventive Treatment with PD-1 Antibody Increases Tissue-resident Memory T Cells Infiltration and Delays Esophageal Carcinogenesis;Cancer Prevention Research;2023-10-19
4. CD39 Expression in Peripheral T Cells is Associated with Clinicopathological Characteristics in Patients with Cervical Cancer;IRAN J IMMUNOL;2023
5. Bibliometric and visualized analysis of the top-100 highly cited articles on immunotherapy for endometrial cancer;Medicine;2023-07-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3